UB Paderborn / Katalog / Suche / in CDI

Hematological findings and complications of COVID‐19

American journal of hematology, 2020-07, Vol.95 (7), p.834-847

2020

Link zum Volltext

Verfügbarkeit prüfen

Updated clinical models for VTE prediction in hospitalized medical patients

Thrombosis research, 2018-04, Vol.164, p.S62-S69

2018

Link zum Volltext

Verfügbarkeit prüfen

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

Clinical and Applied Thrombosis/Hemostasis, 2018-12, Vol.24 (9_suppl), p.8S-28S

2018

Link zum Volltext

Verfügbarkeit prüfen

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Thrombosis and haemostasis, 2020-12, Vol.120 (12), p.1597

2020

Link zum Volltext

Verfügbarkeit prüfen

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination

Clinical and Applied Thrombosis/Hemostasis, 2021, Vol.27, p.10760296211021498

2021

Link zum Volltext

Verfügbarkeit prüfen

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28, p.10760296211056648

2022

Link zum Volltext

Verfügbarkeit prüfen

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1793-1800

2017

Link zum Volltext

Verfügbarkeit prüfen

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Thrombosis research, 2020-07, Vol.191, p.S50-S57

2020

Link zum Volltext

Verfügbarkeit prüfen

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Thrombosis research, 2020-03, Vol.187, p.170-179

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1372-1381

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Critical reviews in oncogenesis, 2017, Vol.22 (3-4), p.219

2017

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

Clinical and Applied Thrombosis/Hemostasis, 2022, Vol.28, p.107602962210979-10760296221097969

2022

Link zum Volltext

Verfügbarkeit prüfen

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Medical engineering & physics, 2017-12, Vol.50, p.50-58

2017

Link zum Volltext

Verfügbarkeit prüfen

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

Thrombosis and haemostasis, 2012-06, Vol.107 (6), p.1044

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

International journal of oncology, 2017-12, Vol.51 (6), p.1747-1756

2017

Link zum Volltext

Verfügbarkeit prüfen

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.107602962110339-10760296211033906

2021

Link zum Volltext

Verfügbarkeit prüfen

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Link zum Volltext

Verfügbarkeit prüfen

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Link zum Volltext

Verfügbarkeit prüfen

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Therapeutics and clinical risk management, 2014-01, Vol.10 (default), p.423-436

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Thrombosis journal, 2017-03, Vol.15 (1), p.9-9, Article 9

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Thrombosis research, 2015-12, Vol.136 (6), p.1273-1279

2015

Link zum Volltext

Verfügbarkeit prüfen

Newer anticoagulants in 2009

Journal of thrombosis and thrombolysis, 2010, Vol.29 (1), p.92-104

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-07, Vol.3 (3), p.e309-e315

2019

Link zum Volltext

Verfügbarkeit prüfen

Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis, 2022-01, Vol.28, p.1076029620939181-1076029620939181

2022

Link zum Volltext

Verfügbarkeit prüfen

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28, p.107602962211382

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Hematological findings and complications of COVID‐19

Updated clinical models for VTE prediction in hospitalized medical patients

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

Modelling of thrombin generation under flow in realistic left anterior descending geometries

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Newer anticoagulants in 2009

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

Aktive Filter

Suchergebnisse filtern